MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

Search

Natera Inc

Closed

SectorHealthcare

143.3 -3.25

Overview

Share price change

24h

Current

Min

142.75

Max

148.73

Key metrics

By Trading Economics

Income

-13M

-67M

Sales

26M

502M

Profit margin

-13.338

Employees

4,424

EBITDA

-33M

-79M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+44.45% upside

Dividends

By Dow Jones

Next Earnings

7 sie 2025

Market Stats

By TradingEconomics

Market Cap

301M

22B

Previous open

146.55

Previous close

143.3

News Sentiment

By Acuity

22%

78%

52 / 376 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Natera Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 lip 2025, 23:34 UTC

Acquisitions, Mergers, Takeovers

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

17 lip 2025, 21:14 UTC

Acquisitions, Mergers, Takeovers

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

17 lip 2025, 21:04 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

17 lip 2025, 23:43 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

17 lip 2025, 23:42 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

17 lip 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

17 lip 2025, 22:46 UTC

Acquisitions, Mergers, Takeovers

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

17 lip 2025, 22:46 UTC

Acquisitions, Mergers, Takeovers

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

17 lip 2025, 22:43 UTC

Acquisitions, Mergers, Takeovers

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

17 lip 2025, 22:43 UTC

Acquisitions, Mergers, Takeovers

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

17 lip 2025, 22:40 UTC

Acquisitions, Mergers, Takeovers

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17 lip 2025, 22:40 UTC

Acquisitions, Mergers, Takeovers

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17 lip 2025, 22:30 UTC

Market Talk
Earnings

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

17 lip 2025, 22:20 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

17 lip 2025, 22:20 UTC

Market Talk
Earnings

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

17 lip 2025, 22:04 UTC

Market Talk
Earnings

Netflix Redesign Done to Match Current Capabilities -- Market Talk

17 lip 2025, 22:03 UTC

Acquisitions, Mergers, Takeovers

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

17 lip 2025, 21:58 UTC

Market Talk
Earnings

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

17 lip 2025, 21:57 UTC

Earnings

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17 lip 2025, 21:47 UTC

Earnings

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

17 lip 2025, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 lip 2025, 21:45 UTC

Market Talk

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

17 lip 2025, 21:38 UTC

Acquisitions, Mergers, Takeovers

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

17 lip 2025, 21:22 UTC

Acquisitions, Mergers, Takeovers

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17 lip 2025, 21:05 UTC

Earnings

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17 lip 2025, 21:04 UTC

Acquisitions, Mergers, Takeovers

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

17 lip 2025, 21:02 UTC

Acquisitions, Mergers, Takeovers

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17 lip 2025, 20:59 UTC

Acquisitions, Mergers, Takeovers

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

17 lip 2025, 20:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

17 lip 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Natera Inc Forecast

Price Target

By TipRanks

44.45% upside

12 Months Forecast

Average 207.11 USD  44.45%

High 251 USD

Low 185 USD

Based on 10 Wall Street analysts offering 12 month price targets forNatera Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

10

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

153.79 / N/ASupport & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

52 / 376 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.